Shanghai HeartCare Medical Technology Corporation Limited (HeartCare-B) filed its Monthly Return with Hong Kong Exchanges and Clearing on 6 May 2026, covering the period ended 30 April 2026. The filing shows no changes in authorised or issued share capital during the month.

Authorised / Registered Capital • Ordinary shares remain at 38.83 million shares with a par value of RMB 1.00 each, split into:  – 31.57 million H shares listed in Hong Kong  – 7.27 million unlisted shares

Issued Shares and Treasury Shares • Total issued shares stayed at 31.57 million. • Listed H shares: 30.59 million issued (excluding treasury) and 0.97 million held in treasury, unchanged from March. • Unlisted shares: 7.27 million, with no treasury position or movement.

Public Float • HeartCare-B confirmed compliance with the Main Board’s 25 % minimum public-float requirement as at 30 April 2026.

Capital Instruments • The company reported no outstanding or new share options, warrants, convertibles or other agreements/arrangements to issue shares during the month.

With no equity movements recorded, HeartCare-B’s share structure and capital base remained stable through April 2026.